SoniVie
tech seeking to treat hypertension through the use of ultrasound
SoniVie has raised €56M across 1 funding round from 4 investors, most recently a Series C round in Jan 2023. Based in Italy; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€56M
€55,699,963
Funding rounds
1
Investors
4
distinct backers
Active since
2023-01
latest 2023-01
Funding by year
EUR raised per yearSoniVie — funding by year — interactive chart.
Data table
| SoniVie — funding by year | |
|---|---|
| 2023 | €56M |
Signals
High confidenceRaise-next likelihood9
base rate 50% for Series C
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-01-12 | Series C | €56M | Andera Partners,Omega Funds,Supernova Invest,TechWald | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Bending Spoons€1.7BItaly · Software
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
Global coverage: FundingData